Division of Clinical Evidence and Analysis 1 (Clinical Policy and Quality)
View detailed information about Division of Clinical Evidence and Analysis 1 (Clinical Policy and Quality), including compliance records, people, and regulatory data.
Comprehensive profile of Division of Clinical Evidence and Analysis 1 (Clinical Policy and Quality), including its role, location, and regulatory activities.
biologics • December 7, 2023
drugs • March 2, 2010
device • November 16, 2023
biologics • September 25, 2023
drugs • September 3, 2021
drugs • May 28, 2015
device • Unknown Date
device • February 27, 2020
drugs • May 13, 2016
drugs • September 11, 2015
drugs • July 31, 2018
biologics • November 11, 2019
drugs • July 2, 2021
biologics • December 16, 2016
drugs • April 30, 2024
device • May 10, 2022
biologics • January 16, 2020
drugs • September 2, 2020
biologics • June 23, 2023
drugs • September 22, 2017
Showing 1 to 20 of 20 records
Name
Division of Clinical Evidence and Analysis 1 (Clinical Policy and Quality)
Abbreviation
DCEA 1
Country
USA
Postal Code
20993
State/Province
Maryland
City
Silver Spring
Address
10903 New Hampshire Avenue, WO66-5521
Office Website
Visit WebsiteID: 5f95da17-30bb-423f-b892-5ea041823fbd
Access our comprehensive quality intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.